Proactive events

Proactive One2One Investor Forum

16 September 2021 | London


Hearing the inside story and understanding the team behind the performance is crucial to making informed decisions. Join us at our next Proactive event to see leading growth companies make their pitch

Leading companies pitching

Poolbeg Pharma PLC

Poolbeg Pharma PLC is a clinical stage infectious disease pharmaceutical company, with a novel capital light clinical model which enables it to develop multiple products faster and more cost effectively than the traditional biotech model. The...

Faron Pharmaceuticals Oy

Faron is a clinical stage biopharmaceutical company developing novel treatments for medical conditions with significant unmet needs. The company currently has a pipeline based on the receptors involved in regulation of immune response in oncology and...

Samarkand Group PLC

Samarkand Group PLC is a cross-border eCommerce company focused on connecting Western brands with China, the world’s largest eCommerce market. The company's proprietary software platform, Nomad, covers commerce, distribution, logistics, payments,...

Destiny Pharma PLC

Destiny Pharma is a clinical stage, innovative biotechnology company focused on the development of novel medicines that can prevent life-threatening infections. Its pipeline has novel microbiome-based biotherapeutics and XF drug clinical assets...

Meet the real story

Join our audience of astute high net worth investors, fund managers, private client brokers and analysts

Look beyond the numbers and meet the people creating the value for shareholders

Each company has a presentation slot followed by Q & A, giving you the chance to discover the real story

Watch the event afterwards on our YouTube channel

Proactive events

The best event for investors looking for the insights that keep you a step ahead of the crowd

See more Proactive events >

One2one investor forums are suitable for sophisticated private investors, private client brokers, fund managers, financial institutions, hedge funds, buy and sell side analysts and journalists. The event is not suitable for people pursuing commercial opportunities.